ABORDANDO A FIBRILAÇÃO ATRIAL: DESAFIOS E ESTRATÉGIAS PARA O TRATAMENTO E PREVENÇÃO

Authors

  • Mauro Alexandre Caixeta Acadêmicos de Medicina pela Universidade Federal de Alagoas
  • Laura Mansur Ferreira de Oliveira Acadêmicos de Medicina pela Universidade Federal de Alagoas
  • Felipe Matheus Vitorino de Mattos Silva Acadêmicos de Medicina pela Universidade Federal de Alagoas
  • Mirelly da Trindade Almeida Acadêmicos de Medicina pela Universidade Federal de Alagoas
  • Caio Calheiros Camello Acadêmicos de Medicina pela Universidade Federal de Alagoas
  • Bruna da Rocha Bezerra Acadêmica de medicina pela Faculdades Integradas do Extremo Sul da Bahia - UNESULBAHIA
  • Pedro Victor Alves Castro Médico pela UNCISAL
  • Ary Aragão Cabral Vieira Médico pela UNCISAL
  • Mateus Felipe Fernandes De Miranda Médico pela ITPAC Porto Nacional- TO
  • Mateus Menezes Monte Médico pela Unifacid
  • Adoaldo Fernandes Gomes Neto Médica pelo Centro Universitário UniFacid Wyden
  • Luana Moura Luz Fé Médica pelo Centro Universitário UniFacid Wyden

DOI:

https://doi.org/10.36557/pbpc.v3i1.16

Keywords:

Atrial Fibrillation, Therapy, Management, Diagnosis.

Abstract

Atrial fibrillation (AF) is a common cardiac arrhythmia, associated with an increased risk of stroke, heart failure, and mortality. This summary addresses the clinical challenges and emerging strategies in the treatment and prevention of AF. Effective management of AF requires a multidisciplinary approach including rhythm control, rate control, and prevention of thromboembolic complications. Therapeutic options include antiarrhythmic medications, electrical cardioversion, catheter ablation, and anticoagulation therapy. However, the choice of optimal treatment should be personalized, considering individual risk factors, comorbidities, and patient preferences. Furthermore, recent advances in technology, such as the use of remote monitoring devices and artificial intelligence, offer new opportunities for early detection and optimized management of AF. Despite advancements, significant challenges persist, including preventing thromboembolic events without increasing bleeding risk and identifying new therapeutic targets. Therefore, an integrated and updated approach is essential to improve clinical outcomes and quality of life for patients with AF.

References

Asad, Z.; Abbas, M. & Javed, I. (2018). Obesity is associated with incident atrial fibrillation independent of gender: A meta-analysis. Journal of Cardiovascular Electrophysiology, May;29(5):725-732. DOI: 1111/jce.13458

Aune, D.; Feng, T.; Schlesinger, S.; Janszky, I.; Norat, T.; Riboli, E. (2018). Diabetes mellitus, blood glucose and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies. Journal Diabetes Complications, 32(5):501-511. DOI: 10.1016/j.jdiacomp.2018.02.004

Aune, D.; Schlesinger, S.; Norat, T.; Riboli, E. (2018). Tobacco smoking and the risk of atrial fibrillation: A systematic review and meta-analysis of prospective studies. European Journal of Preventive Cardiology, 25(13):1437-1451. DOI: 10.1177/2047487318780435

Aune, D.; Sen, A.; ó'Hartaigh, B.; Janszky, I.; Romundstad, P. R.; Tonstad, S., Vatten, J. L. (2017). Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality -A systematic review and dose-response meta-analysis of prospective studies.Nutrition, Metabolism and Cardiovascular Diseases, 27(6):504-517. DOI: 10.1016/j.numecd.2017.04.004

Chokesuwattanaskul, R.; Thongprayoon, C.; Bathini, T.; O'Corragain, O. A.;Sharma, K.;Prechawat, S.; Ungprasert, P.;Watthanasuntorn, K.; Pachariyanon, P.; Cheungpasitporn,W.(2019). Incidence of atrial fibrillation in pregnancy and clinical significance: a meta-analysis. Advances In Medical Sciences, Elsevier BV, 64 (2); 415-422. DOI: 10.1016/j.advms.2019.07.003

Dilaveris, P. E. & Kennedy, H. L. (2016) Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact. Clinical Cardiology, [S.L.], 40(6); 413-418. http://dx.doi.org/10.1002/clc.22667

Gallagher, C.; Hendriks, J. M. L.; Eliott, A. D.; Wong, C. X; Rangnekar, G.; Middeldorp, M. E.; Mahajan, R.; Lau, D. H.; Sanders, P. (2017). Alcohol and incident atrial fibrillation –A systematic review and meta-analysis. International Journal of Cardiology, 246 (2017);46–52. DOI: 10.1016/j.ijcard.2017.05.133

Groh, C. A.; Vittinghoff, E.; Benjamin, E. J.; Dupuis, J.; Marcus, G. M. (2019). Childhood Tobacco Smoke Exposure and Risk of Atrial Fibrillation in Adulthood. Journal of the American College of Cardiology, 74(13); 1658-1664. DOI: 10.1016/j.jacc.2019.07.060

Katsi, V.; Georgiopoulos, G.; Marketou, M.; Oikonomou, D.; Parthenakis, F.; Makris, T.; Nihoyannopoulos, P.; Vardas, P.; Tousoulis, D. (2017). Atrial fibrillation in pregnancy: a growing challeng. Current Medical Research Opinion, 33(8):1497-1504. DOI: 10.1080/03007995.2017.1330257

Lavie, C. J.; Pandey, A.; Lau, D. H.; Alpert, M. A.; Sanders, P. (2017). Obesity and Atrial Fibrillation Prevalence, Pathogenesis and Prognosis: Effects of Weight Loss and Exercise. Journal of the American College of Cardiology. 70 (16),35. DOI: 10.1016 /j.jacc.2017.09.002

Published

2024-04-22

Issue

Section

Ciências da Saúde